Alzamend Neuro, Inc. (ALZN)
1.13
+0.01
(+0.89%)
USD |
NASDAQ |
Oct 23, 16:00
1.13
0.00 (0.00%)
After-Hours: 20:00
Alzamend Neuro Price : 1.13 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.11 | 1.190 | 1.10 | 1.13 | 29088.00 |
| Oct 22, 2026 | 1.25 | 1.29 | 1.12 | 1.12 | 15286.00 |
| Oct 21, 2026 | 1.29 | 1.39 | 1.25 | 1.25 | 10551.00 |
| Oct 20, 2026 | 1.30 | 1.33 | 1.28 | 1.30 | 10917.00 |
| Oct 19, 2026 | 1.34 | 1.345 | 1.31 | 1.33 | 6522.00 |
| Oct 16, 2026 | 1.29 | 1.34 | 1.25 | 1.30 | 15867.00 |
| Oct 15, 2026 | 1.32 | 1.335 | 1.28 | 1.28 | 14972.00 |
| Oct 14, 2026 | 1.31 | 1.396 | 1.31 | 1.35 | 23163.00 |
| Oct 13, 2026 | 1.430 | 1.430 | 1.30 | 1.35 | 18051.00 |
| Oct 12, 2026 | 1.40 | 1.429 | 1.31 | 1.31 | 17032.00 |
| Oct 09, 2026 | 1.43 | 1.43 | 1.34 | 1.34 | 13299.00 |
| Oct 08, 2026 | 1.32 | 1.35 | 1.22 | 1.34 | 6964.00 |
| Oct 07, 2026 | 1.37 | 1.42 | 1.34 | 1.37 | 18886.00 |
| Oct 06, 2026 | 1.435 | 1.435 | 1.343 | 1.37 | 32055.00 |
| Oct 05, 2026 | 1.38 | 1.48 | 1.375 | 1.41 | 25424.00 |
| Oct 02, 2026 | 1.41 | 1.48 | 1.20 | 1.37 | 236382.0 |
| Oct 01, 2026 | 1.72 | 1.72 | 1.26 | 1.315 | 150749.0 |
| Sep 30, 2026 | 1.84 | 1.84 | 1.73 | 1.73 | 21694.00 |
| Sep 29, 2026 | 1.745 | 1.85 | 1.740 | 1.82 | 49609.00 |
| Sep 28, 2026 | 1.80 | 1.920 | 1.73 | 1.73 | 83828.00 |
| Sep 25, 2026 | 1.90 | 1.90 | 1.764 | 1.83 | 23319.00 |
| Sep 24, 2026 | 1.90 | 1.93 | 1.82 | 1.82 | 150562.0 |
| Sep 23, 2026 | 1.93 | 1.95 | 1.93 | 1.94 | 45867.00 |
| Sep 22, 2026 | 1.93 | 1.94 | 1.90 | 1.94 | 91217.00 |
| Sep 21, 2026 | 1.89 | 1.94 | 1.87 | 1.94 | 206807.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Anika Therapeutics, Inc. | 21.42 |
| Savara, Inc. | 4.22 |
| Vericel Corp. | 42.53 |
Price Related Metrics
| Price to Book Value | 0.9397 |
| Earnings Yield | -202.5% |
| Market Cap | 5.453M |